PROSTATE NEOPLASMS
Clinical trials for PROSTATE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASMS trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine-Chemo combo shows promise against advanced prostate cancer
Disease control CompletedThis study tested whether adding a prostate cancer vaccine (PROSTVAC) and chemotherapy (docetaxel) to standard hormone therapy could help men whose prostate cancer had spread. 74 men with metastatic castrate-sensitive prostate cancer took part. The goal was to see if the combinat…
Matched conditions: PROSTATE NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Could a few weeks of radiation be enough for recurrent prostate cancer?
Symptom relief CompletedThis study tested a shorter course of radiation (2–4 weeks instead of 6–7) for men whose prostate cancer came back after prostate removal. The goal was to find the shortest schedule that is safe and tolerable. 30 men participated, and the researchers focused on giving a higher do…
Matched conditions: PROSTATE NEOPLASMS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC
-
Real-World data reveals treatment patterns for advanced prostate cancer
Knowledge-focused CompletedThis study reviewed medical records from over 1,300 men with metastatic prostate cancer that still responds to hormone therapy. Researchers wanted to see how long patients actually take the pills apalutamide or enzalutamide when prescribed by their own doctors in routine care. Th…
Matched conditions: PROSTATE NEOPLASMS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:06 UTC